Grant Programs

NADDI applies annually for a number of diverse grant funding opportunities.The funding is received at various times throughout the year and an announcement is made to all Members on our list server and on the website when grant funds are available and the opening the application process.


NADDI Bottle Tracking Program - OPEN

This program is a collaboration between law enforcement, pharmacies, technology providers and NADDI. The mission of the program is to assist law enforcement efforts to prevent, deter, and investigate the retail theft of prescription drugs, particularly Opioids.  This is accomplished by facilitating steps to enable the placement of a proven resource (a look-alike pharmaceutical bottle) that blends with the pharmacy inventory and that can be electronically tracked.

Contact NADDI Executive Director, Charlie Cichon @ to discuss interest in the bottle tracking program.

After the initial consultation, the respective law enforcement agency may apply for grant funding to assist in covering the expenses for the program.

The grant request shall be submitted on agency letterhead and shall include specific information CLICK HERE for particulars.


Rx Drug Box Program – Currently Closed

The Rx Drug Box Program anticipates funding in the first quarter of 2016.

NADDI is offering law enforcement an opportunity to receive a free locked box to accept unwanted and expired pharmaceuticals every day of the week in their own facility. Previously sponsored by Endo and Zogenix Pharmaceuticals, NADDI will begin accepting letters as soon as new funding arrives. The requests must be authorized and signed by a top LE official on their agency letterhead. To apply for a box, review the information and download the application letter at


LE Grant Program– Currently Closed

The 2016 Law Enforcement Grant Program anticipates funding in the Spring of 2016.

The National Association of Drug Diversion Investigators (NADDI) has an ongoing grant program available to law enforcement applicants only. The grant process has been purposely made to be applicant friendly, while still soliciting the important information so that a fair decision can be made on each application.

Previously sponsored by Purdue Pharma, NADDI will begin accepting letters as soon as new funding arrives.

NADDI wants to thank our generous donors that make these grants possible. It is important to note that our donors do not participate in the selection process in any way, but without their support, these grants would not be possible. 

Grant applications will be reviewed by the NADDI Grant Committees, who will make the final selections. Any questions on the grant program should be directed to:

Charlie Cichon
Executive Director

Lisa McElhaney


"Any criminal act involving a prescription drug."